«The totality of evidence clearly indicates that the more
widespread and appropriate utilization of statins, as adjuncts, not alternatives to
therapeutic lifestyle changes, will yield net benefits in the treatment and primary prevention of heart attacks and strokes, including among high, medium and low risk patients unwilling or unable to adopt
therapeutic lifestyle changes,» said Hennekens.